Post-Ablation cardiac Magnetic resonance to assess Ventricular Tachycardia recurrence (PAM-VT study)
European Heart Journal - Cardiovascular Imaging · 29.01.2024 · 25 (2) · 188-198
DOI: 10.1093/ehjci/jead261 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Heart Journal - Cardiovascular Imaging, online erschienen am 11.10.2023. Verfasst von Ivo Roca-Luque und 20 weiteren Autor:innen. Beteiligte Einrichtung: Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Clínic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain. Hauptthemen laut MEDLINE: Tachycardia, Ventricular, Catheter Ablation. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Emile Letang Grand of Hospital Clinic de Barcelona, Instituto de Salud Carlos III, European Union.
Abstract (Originalsprache)
Aims
Conducting channels (CCs) detected by late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) are related to ventricular tachycardia (VT). The aim of this work was to study the ability of post-ablation LGE-CMR to evaluate ablation lesions. Methods and results This is a prospective study of consecutive patients referred for a scar-related VT ablation. LGE-CMR was performed 6–12 months prior to ablation and 3–6 months after ablation. Scar characteristics of pre- and post-ablation LGE-CMR were compared. During the study period (March 2019−April 2021), 61 consecutive patients underwent scar-related VT ablation after LGE-CMR. Overall, 12 patients were excluded (4 had poor-quality LGE-CMR, 2 died before post-ablation LGE-CMR, and 6 underwent post-ablation LGE-CMR 12 months after ablation). Finally, 49 patients (age: 65.5 ± 9.8 years, 97.9% male, left ventricular ejection fraction: 34.8 ± 10.4%, 87.7% ischaemic cardiomyopathy) were included. Post-ablation LGE-CMR showed a decrease in the number (3.34 ± 1.03 vs. 1.6 ± 0.2; P < 0.0001) and mass (8.45 ± 1.3 vs. 3.5 ± 0.6 g; P < 0.001) of CCs. Arrhythmogenic CCs disappeared in 74.4% of patients. Dark core was detected in 75.5% of patients, and its presence was not related to CC reduction (52.2 ± 7.4% vs. 40.8 ± 10.6%, P = 0.57). VT recurrence after one year follow-up was 16.3%. The presence of two or more channels in the post-ablation LGE-CMR was a predictor of VT recurrence (31.82% vs. 0%, P = 0.0038) with a sensibility of 100% and specificity of 61% (area under the curve 0.82). In the same line, a reduction of CCs < 55% had sensibility of 100% and specificity of 61% (area under the curve 0.83) to predict VT recurrence.
Conclusion
Post-ablation LGE-CMR is feasible, and a reduction in the number of CCs is related with lower risk of VT recurrence. The dark core was not present in all patients. A decrease in VT substrate was also observed in patients without a dark core area in the post-ablation LGE-CMR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Clínic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
- Centre de Diagnòstic per la Imatge, Hospital Clínic, Universitat de Barcelona, Catalonia, Spain.
- Adas3D Medical S.L., Barcelona, Spain.
ORCID-Profile: Ivo Roca-Luque, Eduard Guasch, Andreu Porta-Sanchez, Marta Sitges, Josep Brugada, Lluís Mont
Förderung
- Emile Letang Grand of Hospital Clinic de Barcelona
- Instituto de Salud Carlos III
- European Union
- Generalitat de Catalunya
Zitieren
APA
Roca-Luque, I., Vázquez-Calvo, S., Garre, P., Ortiz-Perez, J. T., Prat-Gonzalez, S., Sanchez-Somonte, P., Ferro, E., Quinto, L., Alarcón, F., Althoff, T., Perea, R. J., Figueras I Ventura, R. M., Guasch, E., Tolosana, J. M., Lorenzatti, D., Morr-Verenzuela, C. I., Porta-Sanchez, A., Arbelo, E., Sitges, M., …, & Mont, L. (2024). Post-Ablation cardiac Magnetic resonance to assess Ventricular Tachycardia recurrence (PAM-VT study). European Heart Journal - Cardiovascular Imaging, 25(2), 188-198. https://doi.org/10.1093/ehjci/jead261
Vancouver
Roca-Luque I, Vázquez-Calvo S, Garre P, Ortiz-Perez JT, Prat-Gonzalez S, Sanchez-Somonte P, et al. Post-Ablation cardiac Magnetic resonance to assess Ventricular Tachycardia recurrence (PAM-VT study). European Heart Journal - Cardiovascular Imaging. 2024;25(2):188-198. doi:10.1093/ehjci/jead261
BibTeX
@article{RocaLuque2024,
author = {Roca-Luque, Ivo and Vázquez-Calvo, Sara and Garre, Paz and Ortiz-Perez, Jose T and Prat-Gonzalez, Susanna and Sanchez-Somonte, Paula and Ferro, Elisenda and Quinto, Levio and Alarcón, Francisco and Althoff, Till and Perea, Rosario Jesús and Figueras I Ventura, Rosa M and Guasch, Eduard and Tolosana, José Maria and Lorenzatti, Daniel and Morr-Verenzuela, Carlos Igor and Porta-Sanchez, Andreu and Arbelo, Elena and Sitges, Marta and Brugada, Josep and Mont, Lluís},
title = {Post-Ablation cardiac Magnetic resonance to assess Ventricular Tachycardia recurrence (PAM-VT study)},
journal = {European Heart Journal - Cardiovascular Imaging},
year = {2024},
volume = {25},
number = {2},
pages = {188--198},
doi = {10.1093/ehjci/jead261}
}
EUVIMED